✨ Free AI Report
Molecular Templates, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Molecular Templates, Inc.
Research Preview

Molecular Templates, Inc.: Business Overview, Financials & Competitive Analysis

Molecular Templates, Inc. was a venture-backed biopharmaceutical company developing engineered toxin body (ETB) therapies for cancer treatment. The company is no longer operating as of 2025.

Analyst-debate audio for Molecular Templates, Inc.

AskCyborg analysts argue the bull and bear cases for Molecular Templates, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Molecular Templates, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
1/ 10Challenged

Cyborg Score thesis

Defunct company; no longer a going concern....

Read the full analyst-debate transcript →
Industry Oncology therapeutics development
2 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Molecular Templates, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Molecular Templates, Inc. Overview

Pro stress-test →

Molecular Templates, Inc. was a venture-backed biopharmaceutical company developing engineered toxin body (ETB) therapies for cancer treatment. The company is no longer operating as of 2025.

Strategic Profile

Pro stress-test →

The company developed a proprietary ETB platform with differentiated mechanisms compared to antibody-drug conjugates (ADCs). As of January 2025, the company transitioned to winding down operations under new leadership.

Competitive Landscape

Pro stress-test →

Historical competitors in the antibody-drug conjugate and engineered toxin therapy space included Ambrx, Humanigen, and other cancer-focused biopharmaceutical companies. The company's differentiated ETB platform was designed to compete with traditional ADC therapies.

Industry Context

Molecular Templates, Inc. operates in Oncology therapeutics development.

Key facts

Founded: 2001 · Headquarters: Georgetown, US

What the analysts stress-tested

The top findings that survived the multi-agent debate for Molecular Templates, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Molecular Templates, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

AmbrxAntibody-drug conjugate and targeted biotherapeutics platform→HumanigenBiopharmaceutical company focused on immunotherapy→

Compare Molecular Templates, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Molecular Templates, Inc. operates in Oncology therapeutics development. See how the rest of the sector scores on the Cyborg framework.

Browse Oncology therapeutics development research →
NEW · MCP server

Ask your AI assistant about Molecular Templates, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Molecular Templates, Inc. and its top competitor on Cyborg Score”
“What did Molecular Templates, Inc. do this quarter?”
“Is Molecular Templates, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Molecular Templates, Inc. do?+
Molecular Templates, Inc. was a venture-backed biopharmaceutical company developing engineered toxin body (ETB) therapies for cancer treatment. The company is no longer operating as of 2025.
What is Molecular Templates, Inc.'s Cyborg Score?+
Molecular Templates, Inc. has a Cyborg Score of 1/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Molecular Templates, Inc.'s main competitors?+
Named competitors include Ambrx, Humanigen. The full competitive landscape is in the AskCyborg report.
How can I get the full Molecular Templates, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Molecular Templates, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Molecular Templates, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Anthropic9Dubai Electricity and Water Authority (DEWA)9Emaar Development PJSC9Gold Fields Limited9Western Digital Corporation9Advantest Corporation9Fast Retailing Co., Ltd.9JPMorgan Chase & Co.9Siemens AG9Space Exploration Technologies Corp8Arcellx, Inc.8Gentili Mosconi S.p.A.8Neurogene Inc.8Selvaag Bolig ASA8Satellogic Inc.8Klaveness Combination Carriers ASA8Unusual Machines, Inc.8Shoei Co., Ltd.